Beam Therapeutics, Inc. (BEAM)
27.72
-0.10
(-0.36%)
USD |
NASDAQ |
Dec 31, 16:00
27.71
-0.01
(-0.04%)
After-Hours: 20:00
Beam Therapeutics Free Cash Flow: -352.36M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ANI Pharmaceuticals, Inc. | 136.04M |
| Intellia Therapeutics, Inc. | -412.63M |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Amicus Therapeutics, Inc. | 9.691M |
| Repligen Corp. | 103.47M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -81.48M |
| Cash from Investing (Quarterly) | 65.66M |
| Cash from Financing (Quarterly) | 1.675M |
| Free Cash Flow Per Share (Quarterly) | -0.8432 |
| Free Cash Flow to Equity (Quarterly) | -83.11M |
| Free Cash Flow to Firm (Quarterly) | -86.49M |
| Free Cash Flow Yield | -13.55% |